Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Scinai Immunotherapeutics (SCNI)

Scinai Immunotherapeutics Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SCNI
DateTimeSourceHeadlineSymbolCompany
14/06/202412:26Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SCNIScinai Immunotherapeutics Ltd
13/06/202415:19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SCNIScinai Immunotherapeutics Ltd
13/06/202415:16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SCNIScinai Immunotherapeutics Ltd
13/06/202412:00PR Newswire (US)Scinai Immunotherapeutics Announces Receipt of a Letter of Intent from the European Investment Bank Providing Specific Terms for Conversion of its Loan to Equity.NASDAQ:SCNIScinai Immunotherapeutics Ltd
07/06/202412:00PR Newswire (US)Scinai Immunotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement; Continues to Work with the European Investment Bank to Convert Loan to Equity to Regain Compliance with Nasdaq Minimum Shareholders' Equity RequirementNASDAQ:SCNIScinai Immunotherapeutics Ltd
28/05/202419:14Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SCNIScinai Immunotherapeutics Ltd
24/05/202421:01PR Newswire (US)Scinai Immunotherapeutics Announces Receipt of a Nasdaq Staff Determination Letter Regarding Shareholders' Equity listing requirements and Hearing to Present a Plan for Regaining ComplianceNASDAQ:SCNIScinai Immunotherapeutics Ltd
16/05/202418:49Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCNIScinai Immunotherapeutics Ltd
15/05/202422:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SCNIScinai Immunotherapeutics Ltd
15/05/202421:01PR Newswire (US)Scinai Publishes FY 2023 Financial Statements, Files Annual Report on Form 20-F and Provides Business UpdateNASDAQ:SCNIScinai Immunotherapeutics Ltd
07/05/202415:24Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SCNIScinai Immunotherapeutics Ltd
06/05/202414:21PR Newswire (US)Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and AppealNASDAQ:SCNIScinai Immunotherapeutics Ltd
10/04/202412:00PR Newswire (US)Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schön of UMGNASDAQ:SCNIScinai Immunotherapeutics Ltd
08/04/202422:15AllPennyStocks.comBiotech Rips Following Five-Year Master Service Agreement ReleaseNASDAQ:SCNIScinai Immunotherapeutics Ltd
08/04/202412:00PR Newswire (US)Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing ServicesNASDAQ:SCNIScinai Immunotherapeutics Ltd
12/03/202412:00PR Newswire (US)Scinai leadership to attend BIO-Europe Spring 2024NASDAQ:SCNIScinai Immunotherapeutics Ltd
29/02/202413:45PR Newswire (US)Scinai to showcase its cGMP biologics CDMO and innovative NanoAb pipeline at MIXiii 2024NASDAQ:SCNIScinai Immunotherapeutics Ltd
13/02/202412:00PR Newswire (US)Scinai Welcomes Liat Halpert as Head of Business Development and SalesNASDAQ:SCNIScinai Immunotherapeutics Ltd
30/01/202421:19Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:SCNIScinai Immunotherapeutics Ltd
25/01/202415:26PR Newswire (US)Scinai Immunotherapeutics Congratulates its Co-Lead Scientific Research Collaborator Dirk Görlich on Louis-Jeantet PrizeNASDAQ:SCNIScinai Immunotherapeutics Ltd
24/01/202419:33Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SCNIScinai Immunotherapeutics Ltd
18/01/202416:50Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SCNIScinai Immunotherapeutics Ltd
12/01/202412:32Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:SCNIScinai Immunotherapeutics Ltd
09/01/202413:45Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SCNIScinai Immunotherapeutics Ltd
04/01/202421:37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SCNIScinai Immunotherapeutics Ltd
04/01/202421:01PR Newswire (US)Scinai Immunotherapeutics Announces Closing of Exercise of Outstanding Warrants for $1.69 Million in Gross ProceedsNASDAQ:SCNIScinai Immunotherapeutics Ltd
04/01/202411:15PR Newswire (US)Scinai Immunotherapeutics CEO Issues Letter to ShareholdersNASDAQ:SCNIScinai Immunotherapeutics Ltd
02/01/202414:58Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCNIScinai Immunotherapeutics Ltd
02/01/202414:57Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCNIScinai Immunotherapeutics Ltd
02/01/202414:26Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SCNIScinai Immunotherapeutics Ltd
 Showing the most relevant articles for your search:NASDAQ:SCNI

Your Recent History

Delayed Upgrade Clock